Carolyn Tang
2020
In 2020, Carolyn Tang earned a total compensation of $2.2M as General Counsel at Arcus Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $767,080 |
| Salary | $337,515 |
| Stock Awards | $958,650 |
| Other | $1,200 |
| Total | $2,239,445 |
Tang received $958.7K in stock awards, accounting for 43% of the total pay in 2020.
Tang also received $175K in non-equity incentive plan, $767.1K in option awards, $337.5K in salary and $1.2K in other compensation.
Rankings
In 2020, Carolyn Tang's compensation ranked 5,016th out of 13,090 executives tracked by ExecPay. In other words, Tang earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,016 out of 13,090 | 62nd |
Division Manufacturing | 2,045 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 815 out of 2,254 | 64th |
Industry group Drugs | 704 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 529 out of 1,459 | 64th |
Source: SEC filing on April 20, 2022.
Tang's colleagues
We found five more compensation records of executives who worked with Carolyn Tang at Arcus Biosciences in 2020.
2020
Jennifer Jarrett
Arcus Biosciences
Chief Operating Officer
2020
William Grossman
Arcus Biosciences
Chief Medical Officer
2020
Terry Rosen
Arcus Biosciences
Chief Executive Officer
2020
Juan Jaen
Arcus Biosciences
President and Director
2020
Robert Goeltz
Arcus Biosciences